ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV

ViiV Healthcare and CHAI collaboration delivers second milestone with first filing with the FDA of generic dolutegravir by Aurobindo Pharma for the treatment of HIV LONDON, United-Kingdom, May 26, 2015/African Press Organization (APO)/ — ViiV Healthcare (http://www.viivhealthcare.com), Aurobindo Pharma (http://www.aurobindo.com), and the Clinton Health Access Initiative, Inc. (CHAI) (http://www.clintonhealthaccess.org) announced today that Aurobindo Pharma has […]http://feedproxy.google.com/~r/Appa-sourceTheAfric...